Menu

1 / 6

Novo Nordisk shares jump 6% after lifting 2026 outlook on obesity-drug demand

Business - Latest - Google News·12 days ago
#EcqJtt39
#world#news#finance#billion#crowns
Reading 0:00
15s threshold

Novo Nordisk shares jump 6% after lifting 2026 outlook on obesity-drug demand

Navamya Acharya

Updated Wed, November 4, 2026 at 3:18 AM PST 2 min read

NVO

+6.43%

NOVOb

Investing.com -- Novo Nordisk (NVO) shares jumped as much as 3% on Wednesday before paring gains to trade up 4.2%, after the Danish drugmaker raised its 2026 outlook on stronger-than-expected obesity-drug demand.

The company now expects adjusted sales and adjusted operating profit to range from a 2% decline to 2% growth at constant exchange rates, compared with its previous forecast of a 6% decline to flat.

Third-quarter adjusted sales rose to 79.20 billion Danish crowns from 74.98 billion a year earlier.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.